A comparison of the absorption of Vitamin D with and without pollen

ISRCTN ISRCTN99745836
DOI https://doi.org/10.1186/ISRCTN99745836
Secondary identifying numbers Version 1. 01/07/2011
Submission date
02/07/2012
Registration date
16/07/2012
Last edited
06/12/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Vitamin D deficiency has become a great problem because of lack of sunlight exposure and the relative scarcity of vitamin D in the diet. This study aims to determine whether encapsulation of vitamin D within spores could increase its absorption in the blood in normal healthy volunteers.

Who can participate?
Six normal healthy volunteers who are not taking any medications or over the counter supplements will be recruited.

What does the study involve?
The participants will be randomly allocated either to vitamin D with spore encapsulation or vitamin D without spore encapsulation. Participants will come to the centre twice to test each of the vitamin D preparations and each time we will ask you to attend without having had anything to eat or drink, other than water, from the previous night. We will place a plastic tube (cannula) in your arm to allow blood to be taken without the need for multiple needles to be used. A sample of blood will be taken, after which you will take the first vitamin D supplement.

Blood samples will be taken fasting (time 0), then at 15, 30, 45, 60, 120, 180 and 240 minutes after taking the supplement. Participants will be then given a washout period before being asked to take the other supplement and blood sampling will be repeated as described above.
The blood samples that will be taken will be labelled with a simple number so that they cannot be traced back to you. All samples will be sent for vitamin D analysis at the laboratories at Hull Royal Infirmary. Any additional samples will be destroyed after the vitamin D levels have been measured.
We will take your height, weight and blood pressure as part of the study.

What are the possible benefits and risks of participating?
For most people needle punctures for blood draws do not cause any serious problems. Some people feel faint, and there may be some pain and bruising (or, very rarely, infection) where the needle goes in. Both pollen and vitamin D supplements are freely available on the market and shouldn’t cause any allergic reactions. Please let us know if you have had any problems in the past. All staff in the Clinical Trial Units are qualified to deal with adverse events and there will be a doctor present in the event of something going wrong. You may withdraw from participation in the project at any time and without any disadvantage to yourself of any kind.

Where is the study run from?
Clinical Trials Unit, HONEI project, University of Hull.

When is study starting and how long is it expected to run for?
The study began in May 2012 and is expected to run for 2 months.

Who is funding the study?
Diabetes Endowment Fund, University of Hull.

Who is the main contact?
Dr T Sathyapalan
thozhukat.sathyapalan@hyms.ac.uk

Contact information

Dr Thozhukat Sathyapalan
Scientific

Michael White Diabetes Centre
Hull Royal Infirmary
220 - 236 Anlaby Road
Hull
HU3 2RW
United Kingdom

Study information

Study designDouble blind randomised cross over study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA comparison of the absorption of ergocalciferol with and without pollen: a randomised controlled trial
Study objectivesEncapsulating vitamin D with exine microcapsules enhance its bioavailability in the blood in normal healthy volunteers
Ethics approval(s)Hull York Medical School, University of Hull Ethics Committee, 12 October 2011
Health condition(s) or problem(s) studiedVitamin D absorption in healthy volunteers
InterventionParticipants are randomised to either vitamin D with spore encapsulation or vitamin D without spore encapsulation.

The vitamin D supplement will be taken on an empty stomach after participants have fasted for 10 hours. Blood samples will be taken fasting (time 0), then at 15, 30, 45, 60, 120, 180 and 240 minutes after taking the supplement.

Participants will be then given a 1 month washout period before being asked to take the other supplement and blood sampling was repeated as described above.
Intervention typeSupplement
Primary outcome measureArea under the curve for 25-hydroxy (25OH) vitamin D levels at (time 0), then at 15, 30, 45, 60, 120, 180 and 240 minutes after taking the supplement.
Secondary outcome measures1. Adjusted Calcium
2. Parathyroid hormone

At (time 0), then at 15, 30, 45, 60, 120, 180 and 240 minutes after taking the supplement.
Overall study start date01/05/2012
Completion date30/07/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants6
Key inclusion criteria1. Male or Female subjects between the age of 35-65
2. No concomitant medication or vitamin supplements
3. No concomitant disease processes
4. Body Mass Index 21- 29kg/m2
5. Systolic blood pressure ≤140 mm Hg and diastolic pressure ≤85 mm Hg
Key exclusion criteria1. Concomitant medication or disease processes
2. Body Mass Index <21 and > 29kg/m2
3. Systolic blood pressure >140 mm Hg and or a diastolic pressure >85 mm Hg
4. Subjects taking vitamin D supplements
5. Subjects not willing or able to fast until 12 noon (a total of 14 hours)
6. Subjects taking any food supplements including pollen
Date of first enrolment01/05/2012
Date of final enrolment30/07/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Michael White Diabetes Centre
Hull
HU3 2RW
United Kingdom

Sponsor information

University of Hull (UK)
University/education

c/o Mr Jonathan Cant
Research and Contracts Manager
Research Funding Office
The Enterprise Centre
Hull
HU6 7RX
England
United Kingdom

ROR logo "ROR" https://ror.org/04nkhwh30

Funders

Funder type

University/education

University of Hull (UK) - Diabetes Endowment Fund

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

06/12/2019: No publications found, verifying study status with principal investigator
22/08/2016: No publications found, verifying study status with principal investigator